Table 4.
Baseline characteristics of our SCA patients versus VerifyNow test results.
| Nonresistant% | Resistant% | P value | |
|---|---|---|---|
| Age | 56.9 ± 8.48 | 62 ± 8.02 | 0.9 |
| Sex | 0.41 | ||
| Male | 58.3% | 20% | |
| Female | 41.7% | 80% | |
| SCA type | 0.2 | ||
| ST (+) | 36% | 60% | |
| ST (−) | 64% | 40% | |
| Familial ACD | 0.8 | ||
| Presence | 2.8% | 0% | |
| Absence | 97.2% | 100% | |
| Personal ACD | 0.3 | ||
| Presence | 41.7% | 20% | |
| Absence | 58.3% | 80% | |
| Diabetes | 0.6 | ||
| Presence | 40.3% | 40% | |
| Absence | 59.7% | 60% | |
| HTA | 0.46 | ||
| Presence | 47.2% | 60% | |
| Absence | 52.8% | 40% | |
| Dyslipidemia | 0.22 | ||
| Presence | 16.7% | 40% | |
| Absence | 83.3% | 60% | |
| Smoking | 0.6 | ||
| Presence | 40.3% | 40% | |
| Absence | 59.7% | 60% | |
| Creatinine (mg/L) | 11.6 ± 10.87 | 15 ± 4.34 | 0.01∗ |
| Fibrinogen | 3.57 ± 1.06 | 5.03 ± 1.14 | 0.04∗ |
| Pq | 242333 ± 102412 | 159427 ± 79609 | 0.04∗ |
| IPP | 0.03∗ | ||
| Used | 50.38% | 60% | |
| Nonused | 49.62% | 40% |
∗Statistically significant.